KSQ THERAPEUTICS
KSQ Therapeutics is pioneering High-Confidence Drug Development: a fundamentally new approach to R&D where the majority of the de-risking work is done prior to the generation of therapeutic drug candidates. Powered by our proprietary CRISPRomics™ drug discovery engine, their team has elucidated the function that each human gene plays in multiple diseases, providing a unique and more comprehensive understanding of disease biology. The quality of these insights enables their scientists to rapidly identify and validate high-confidence, patient-tailored, novel drug targets and then focus their collective efforts on the development of medicines with the greatest potential to impact the lives of patients. KSQ has initiated a pipeline of preclinical discovery programs and was founded in 2015.
KSQ THERAPEUTICS
Industry:
Biopharma Biotechnology Pharmaceutical Therapeutics
Founded:
2015-01-01
Address:
Cambridge, Massachusetts, United States
Country:
United States
Website Url:
http://www.ksqtx.com
Total Employee:
11+
Status:
Active
Contact:
(617)674-9150
Total Funding:
156 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Analytics LetsEncrypt Google Tag Manager WordPress Content Delivery Network Google Universal Analytics Font Awesome Wordpress Plugins
Similar Organizations
Regeneron
Regeneron Pharmaceuticals is a biotechnology company that invents life-transforming medicines for people with serious diseases.
Rani Therapeutics
Rani Therapeutics develops bio-therapeutics technology for the oral delivery of large drug molecules.
Resonant Therapeutics
Resonant Therapeutics is a scalable tumor microenvironment platform that speeds up therapeutic & goal discovery.
Rondo Therapeutics
Rondo Therapeutics creates novel bispecific antibodies that activate the immune system to fight cancer.
Rubius Therapeutics
Rubius has developed the technology to grow, genetically engineer and mature long-circulating Red-Cell Therapeutics.
Nirogy Therapeutics
Nirogy Therapeutics is focusing on small-molecule drugs that target the solute carrier family of transporter proteins (SLCTs).
nQ Medical
nQ Medical is a neurotechnology company allowing Data Defined Disease Management via digital biomarkers using AI.
Nodexus
Nodexus is democratizing access to live single cells for applications including gene editing, drug development, and more.
Viracta Therapeutics
Viracta Therapeutics is a precision oncology company focused on new treatment of virus-associated malignancies.
MDI Therapeutics
MDI Therapeutics is a operator of an discovery stage company focused on developing novel therapies for fibrotic diseases.
Melior Discovery
Melior Discovery offers a pharmacology platform to identify novel indications for pre-clinical development stage drug candidates.
Manus Bio
Manus Bio makes nature accessible and affordable for a growing society.
MyoScience
MyoScience develops and commercializes technology-driven dermatological products.
Moderna Therapeutics
Moderna Therapeutics is a biotechnology company that specializes in drug discovery and drug development based on messenger RNA.
Locus Biosciences
Locus Biosciences develops CRISPR-engineered precision antibacterial platform designed to revolutionize the treatment of bacterial disease.
Alpha Genesis, Inc.
Alpha Genesis is a full=service primate research center that provides nonhuman primate products and bio-research services world-wide
Antisense Therapeutics
Antisense Therapeutics is a biopharmaceutical drug discovery and development company.
Axial Biotherapeutics
Axial Therapeutics is a clinical stage biopharmaceutical company harnessing the gut-brain axis to develop novel Central Nervous System.
AQUA Therapeutics
AQUA Therapeutics primarily engages in the development of therapeutic drugs for the treatment of fibrotic diseases.
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
AmacaThera
AmacaThera's injectable hydrogel platform provides localized, sustained drug delivery to improve patient outcomes.
Arbor Biotechnologies
Arbor Biotechnologies is an operator of a bio-discovery company intended to provide human diagnostic development services.
Acylin Therapeutics
Acylin Therapeutics operates in the pharmaceutical and drug manufacturing industry developing inhibitors of cellular acetylation.
Aclaris Therapeutics
Aclaris Therapeutics is a specialty pharmaceutical company engaged in developing dermatologic therapies.
Alloy Therapeutics
Alloy Therapeutics is a biotech company that makes medicine by democratizing access to foundational drug discovery platforms and services.
Anaeropharma Science
Anaeropharma is a biopharmaceutical company engaged in research and development.
Aptevo Therapeutics
Aptevo Therapeutics is a biotech company primarily focused on bringing novel oncology and hematology therapeutics to market.
Acies Bio
Acies Bio is a biotechnology CRO offering state-of-the-art R&D services to pharmaceutical, chemical, biotech and food industries.
Axcella
Axcella is a biotechnology company that treats diseases using endogenous metabolic modulators.
Amytrx Therapeutics
Amytrx Therapeutics is a biopharmaceutical company that advances the next generation of new anti-inflammatory peptide therapies.
Auransa
A clinical stage drug development company who aims to invent novel drugs for hard-to-treat diseases using its proprietary AI platform
Astrocyte Pharmaceuticals
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain injury patients.
EIP Pharma
EIP Pharma Provides Healthcare Services.
ESSA Pharma
ESSA Pharma is a biotechnology company that develops new drugs for prostate cancer.
Blade Therapeutics
Blade Therapeutics is a discovery stage drug development company.
BioQ Pharma
BioQ Pharma is a late stage specialty pharmaceutical company focused on developing.
BlinkBio
BlinkBio employs specialized Bioorthogonal chemistries for the delivery of next generation medicines.
Faraday Pharmaceuticals
Faraday Pharmaceuticals is an early-stage therapeutics company focused on developing novel therapies to treat ischemia-reperfusion injury.
Triana Biomedicines
Triana Biomedicines is a developer of a molecular glue discovery platform to regulate disease.
Tau Therapeutics
Tau Therapeutics engages in the R&D, repositioning and commercialization of calcium T-channel therapies for oncology and other diseases.
Tetragenetics
Tetragenetics helps people seeking a cost-effective alternative platform technology for the production of genetically engineered proteins.
Jounce Therapeutics
Jounce Therapeutics is developing cancer immune-therapies to harness the immune system to attack cancerous cells and tumors.
Ultivue
Ultivue is a biotechnology company that specializes in tissue imaging, diagnostics, and multiplexing.
Kernal Biologics
Kernalbio creates mRNA therapies that instruct specific cells on how to make their own medicine.
KeifeRx
KeifeRx is a biotech company focused on the discovery of disease-modifying treatments for neurodegenerative illnesses.
1910 Genetics
1910 Genetics is a biotechnology company integrating AI, computation, and biological automation to improve drug development.
Sonnet BioTherapeutics
Sonnet BioTherapeutics is a biotechnology company for innovating biologic drugs of the single or bispecific mechanism of action.
Silk Therapeutics
Silk Therapeutics is a biotech company that offers skincare products for human health and wellness.
SyntheX
SyntheX is a biotechnology company reimagining precision therapeutics with new drug discovery technologies focused on protein modulation.
Stealth BioTherapeutics
Stealth BioTherapeutics is a clinical-stage biotechnology company focused on genetic diseases.
Selecta Biosciences
Selecta Biosciences is a clinical-stage biotechnology company with an unrelenting commitment to overcoming immunogenicity.
Sorbent Therapeutics
Sorbent Therapeutics develops fluid-retaining polymers for kidney disease therapeutics.
Stemgenics
Stemgenics is a developer of a technology that converts mature skin cells into personalized stem cells.
Standigm
Standigm is an AI-driven workflow drug discovery company that aims to improve the success rates and efficiency of new drug development.
Design Pharmaceuticals
Design Pharma has a unique suite of proprietary technologies that enable the discovery and biosynthetic production of drug candidates.
DeepBiome Therapeutics
DeepBiome Therapeutics is an operator of a biotechnology company intended to develop a new drug discovery platform.
Delpor
Delpor is a biotechnology company developing drug delivery technologies to transport proteins, peptides, and small molecules.
Dyve Biosciences
Dyve creates novel therapeutics using proprietary science that leverages the skin as a portal for systemic delivery.
Hyasynth Bio
Hyasynth Bio is inventing new ways to make products using industrial microorganisms.
HiFiBiO
HiFiBiO provides proprietary single cell technologies for applications in drug and biomarker discovery and development.
Heptares Therapeutics
Heptares Therapeutics develops novel, small-molecule drugs for G-protein-coupled receptors (GPCRs).
Harbour Antibodies
Harbour Antibodies uses transgenic mouse technology for engineering mice to produce high affinity human antibodies.
Innogen Pharmaceutical
Innogen Pharmaceutical Technology is a high-tech, innovation-driven international pharmaceutical manufacturing and R&D company.
iCo Therapeutics
ICo Therapeutics is focused on the research and development of drug delivery technologies.
Intabio
Intabio is a developer of a real-time protein analytics platform used to transform the development of biotherapeutic drug.
Intensity Therapeutics
Intensity Therapeutics is a biopharmaceutical company that provides chemotherapy treatment for cancer patients.
Iconic Therapeutics
Iconic Therapeutics develops and commercializes immunoconjugate proteins that trigger the immune system to destroy invader cells.
GITR
GITR develops therapies to enhance the immune system by enabling T cells to be more effective in attacking cancer cells.
Geneos Therapeutics
Geneos Therapeutics is a developer of a neo-antigen based personalized immunotherapy designed to offer cancer treatment.
G-CON Manufacturing
G-CON Manufacturing designs, produces, and installs prefabricated cleanrooms called PODs.
Omniome
Omniome engages in developing a proprietary DNA sequencing platform capable of delivering unsurpassed sequencing accuracy.
Outlook Therapeutics
Outlook Therapeutics is a biopharmaceutical company focused on developing and commercializing monoclonal antibody biosimilar therapeutics.
OnQuality Pharmaceuticals
OnQuality Pharmaceuticals involves in development and commercialization of innovative drugs and drug delivery systems.
OncoResponse
OncoResponse is a company providing cancer research into immunotherapies and the newest technologies for oncologists.
Cirius Therapeutics
Cirius Therapeutics is a clinical-stage company that develops insulin sensitizer for the treatment of non-alcoholic steatohepatitis.
3D Medicines
3D Medicines mission is to improve people’s health through cancer personalized diagnostics and treatment.
Cairn Therapeutics
Cairn Therapeutics transforms the treatment of cancer by overcoming the current limitations of the current therapies.
Carmine Therapeutics
Carmine Therapeutics is developing novel types of gene therapies that utilize extracellular vesicles (EVs) produced in the laboratory.
CAMP4 Therapeutics
CAMP4 Therapeutics is a biotechnology company that uses RNA to restore healthy gene expression.
Cyteir Therapeutics
Cyteir is developing the next generation of synthetic lethal therapies to treat cancer.
Cadence Health
Cadence, a pharma startup, aims to switch a birth control pill over-the-counter to create easy and affordable access to contraceptives.
Cour Pharmaceuticals Development
Cour Pharmaceuticals Development is developing nanoparticle technology to help reset the immune system of multiple sclerosis (MS) patients.
Cleave Therapeutics
Cleave Therapeutics is focused on protein homeostasis and stress pathways in cancer and neurodegeneration.
Prelude Therapeutics
Prelude Therapeutics designs and develops small molecule therapies targeting key drivers of cancer cell growth and resistance.
Galectin Therapeutics
Galectin Therapeutics uses galectin science and drug development to create new therapies for fibrotic diseases and cancer.
Pear Therapeutics
Pear Therapeutics is a software-based digital therapeutics platform designed to treat disease and enhance the efficacy of pharmaceuticals.
Phenex Pharmaceuticals
Phenex Pharmaceuticals is a drug discovery and development company focused on developing novel pharmaceuticals.
PRISM BioLab
PRISM develop therapeutic drugs that cure these intractable diseases using our unique peptide mimic technology.
Prellis Biologics
Prellis employs holographic tissue printing technology with fully human antibody discovery, in vitro human disease and ADME/Tox models.
Plato BioPharma
Plato BioPharma is a world-class preclinical drug discovery CRO specializing in vivo physiological and pharmacological studies.
Current Advisors List
Board_member
Advisor
Board_member
Board_member
Board_member
Current Employees Featured
Kathleen Kelly Associate Director, Program Management @ KSQ Therapeutics
Associate Director, Program Management
2020-12-01
John Trzupek Chief Business Officer @ KSQ Therapeutics
Chief Business Officer
2019-04-01
Frank Stegmeier CSO @ KSQ Therapeutics
CSO
2015-12-01
David Sabatini Founder @ KSQ Therapeutics
Founder
Founder
Investors List
Baillie Gifford
Baillie Gifford investment in Series C - KSQ Therapeutics
Cowen Healthcare Investments
Cowen Healthcare Investments investment in Series C - KSQ Therapeutics
Alexandria Real Estate Equities
Alexandria Real Estate Equities investment in Series C - KSQ Therapeutics
ARCH Venture Partners
ARCH Venture Partners investment in Series C - KSQ Therapeutics
Invus
Invus investment in Series C - KSQ Therapeutics
Polaris Partners
Polaris Partners investment in Series C - KSQ Therapeutics
Lilly Asia Ventures
Lilly Asia Ventures investment in Series C - KSQ Therapeutics
Flagship Pioneering
Flagship Pioneering investment in Series C - KSQ Therapeutics
Alexandria Real Estate Equities
Alexandria Real Estate Equities investment in Series B - KSQ Therapeutics
ARCH Venture Partners
ARCH Venture Partners investment in Series B - KSQ Therapeutics
Official Site Inspections
http://www.ksqtx.com Semrush global rank: 3.32 M Semrush visits lastest month: 4.87 K
- Host name: 224.179.63.50.host.secureserver.net
- IP address: 50.63.179.224
- Location: Scottsdale United States
- Latitude: 33.6013
- Longitude: -111.8867
- Metro Code: 753
- Timezone: America/Phoenix
- Postal: 85260
More informations about "KSQ Therapeutics"
Home - KSQ Therapeutics
Advancing our pipeline of CRISPR/Cas9-engineered Tumor Infiltrating Lymphocytes (eTIL ®) programs and our partnered first-in-class candidates for the treatment of cancer.See details»
About - KSQ Therapeutics
He was most recently Senior Vice President, Head of Research at GSK where he led a large organization of scientists and physicians focused on leveraging the science of immunology, human genetics and genomics, and applying …See details»
KSQ Therapeutics - Crunchbase Company Profile
Contact Email info@ksqtx.com Phone Number (617)674-9150 KSQ Therapeutics is pioneering High-Confidence Drug Development: a fundamentally new approach to R&D where the majority of the de-risking work is done prior to the …See details»
KSQ Therapeutics, Inc. | LinkedIn
KSQ Therapeutics, Inc. | 10,215 followers on LinkedIn. KSQ Therapeutics has built an industry-leading genome-scale precision functional genomics platform, called CRISPRomics, to pinpoint ...See details»
KSQ Company Profile 2024: Valuation, Funding & Investors
KSQ General Information Description. Developer of transformative medicines designed to systematically pinpoint the optimal nodal targets of disease with precision. The company's …See details»
KSQ Therapeutics Appoints John Lepore, M.D., to its Board of …
Lexington, Mass., October 22, 2024 — KSQ Therapeutics, Inc. (KSQ), a clinical-stage biotechnology company developing novel treatments for solid tumors, today announced the …See details»
KSQ Therapeutics, Inc. Information - RocketReach
KSQ was founded by thought leaders in the field of functional genomics and pioneers of CRISPR screening technologies, and the company is located in Cambridge, Massachusetts. For more …See details»
KSQ - Company Profile - Tracxn
Nov 16, 2024 KSQ - Drug discovery company employing functional genomics technology. Raised a total funding of $157M over 2 rounds from 11 investors. Founded by David Berry, …See details»
KSQ Therapeutics Company Profile | Management and Employees …
Smith@ksqtx.com: KSQ Therapeutics Top Competitors. Company Employees Revenue Top technologies; Boehringer Ingelheim Venture Fund GmbH. 33: $6.8 M: Precigen Inc. 209: $6.8 …See details»
KSQ Therapeutics - Craft
KSQ Therapeutics develops and deploys precision functional genomics to discover drug therapies. The Company has built a genome-scale precision functional genomics platform, …See details»
KSQ Therapeutics - Overview, News & Similar companies - ZoomInfo
Jul 13, 2023 Who is KSQ Therapeutics. Founded in 2015, KSQ Therapeutics is a privately-held drug discovery company pioneering precision functional genomics technology to …See details»
John Lepore, MD - KSQ Therapeutics - ksqtx.com
Sep 19, 2024 John Lepore, M.D. is CEO-Partner at Flagship Pioneering and CEO of ProFound Therapeutics, an early stage biotechnology company harnessing the expanded human …See details»
KSQ Therapeutics Announces FDA Clearance of IND Application …
Nov 29, 2023 Phase 1/2 clinical study will evaluate the safety, pharmacokinetics, and preliminary efficacy of KSQ-001EX in melanoma, head and neck squamous cell carcinoma, and non-small …See details»
KSQ Therapeutics Announces First Patient Dosed in Clinical …
LEXINGTON, Mass., June 12, 2024 (GLOBE NEWSWIRE) -- KSQ Therapeutics, Inc. (KSQ), a clinical-stage biotechnology company developing treatments for solid tumors, today …See details»
Ono Acquires Multiple Research-Stage Oncology Programs from …
Jan 25, 2023 Ono Pharmaceutical Co., Ltd. (Osaka, Japan; President and CEO: Gyo Sagara; “Ono”) today announced that it has entered an agreement with KSQ Therapeutics (Lexington, …See details»
Partners - KSQ Therapeutics
In July 2023, we entered into a worldwide license and collaboration agreement with Roche for the development and commercialization of KSQ-4279, our first-in-class, potent, and selective …See details»
KSQ’s Competitors, Revenue, Number of Employees, Funding
KSQ’s Profile, Revenue and Employees. KSQ Therapeutics is a biotechnology company that develops genome-based therapeutics for the treatment of cancer and autoimmune diseases. …See details»
KSQ Therapeutics Announces Leadership and Board Additions
Sep 23, 2022 Micah Benson, PhD, promoted to Chief Scientific Officer Tom Leitch joins as Chief Technology Officer Outgoing CSO Frank Stegmeier, PhD, transitions to board of directors …See details»
KSQ Therapeutics, Inc. (KSQ Therapeutics, Inc.) - 药物管线_专利_临 …
KSQ's proprietary CRISPRomics® discovery engine enables genome-scale, in vivo validated, unbiased target discovery across broad therapeutic areas. For more information, please visit …See details»
Careers - KSQ Therapeutics
We do not ask candidates to purchase anything through us or to provide sensitive identifiable information via email. If you have any concerns or questions regarding the authenticity of a job …See details»